Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 616.50
Bid: 617.50
Ask: 618.50
Change: -6.50 (-1.04%)
Spread: 1.00 (0.162%)
Open: 625.00
High: 627.00
Low: 614.00
Prev. Close: 623.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Nov 2008 07:00

28 November 2008 - Tate & Lyle PLC

Tate & Lyle Board Change

Tate & Lyle PLC (the "Company") announces the appointment of Sir Peter Gershon as a non-executive director and Chairman-elect of the Company. Sir Peter will join the Board on 1st February 2009 and will succeed Sir David Lees as Chairman of the Company by the end of 2009.

Sir Peter Gershon has had a distinguished 30 year career in the computer, telecommunications and defence industries. Between 1987 and 1999 he was managing director of STC Telecommunications, GPT and Marconi Electronic Systems. In 2000, he was appointed Chief Executive of the Office of Government Commerce, in which capacity he also headed up the UK Government's Efficiency Review in 2003/ 2004. Amongst his other current activities, Sir Peter is, and will remain, Chairman of Premier Farnell plc.

Sir David Lees, Chairman of Tate & Lyle, said "I am delighted to welcome Peter to the Board of Tate & Lyle and very much look forward to working closely with him in the months ahead as we transition the Chairmanship of Tate & Lyle."

Sir Peter Gershon said "This is an exciting time to be joining Tate & Lyle, following the significant re-shaping of the Group over the last few years under the focused and diligent leadership of Sir David Lees and Iain Ferguson. I am greatly looking forward to working with Sir David, Iain and the rest of the Tate & Lyle Board on the many opportunities and challenges that lie ahead."

END

1. Biographical details are attached

2. In accordance with paragraph 9.6.13 of the Financial Services Authority's Listing Rules, the Company confirms that:

i) Sir Peter Gershon holds or has held directorships in the following publicly quoted companies in the past five years:

Name of Company Date of Appointment Date of Resignation
Premier Farnell PLC 21 June 2004 Current

ii) There are no further disclosures to be made pursuant to paragraph 9.6.13 of the Financial Services Authority's Listing Rules.

For more information contact Tate & Lyle PLC:

Rowan Adams, Director of Corporate Affairs (Media)

Tel: 020 7626 6525 or Mobile: 07713 067542

Tim Lodge, Acting Group Finance Director and Director of Investor Relations

Tel: 020 7626 6525 or Mobile: 07798 837317

Notes to Editor

1. Sir David Lees joined the Board of Tate & Lyle as Chairman on 1 October 1998.

2. About Sir Peter Gershon, CBE, FREng

Sir Peter, aged 61, has been Non-Executive Chairman of Premier Farnell plc since 1 March 2005. He also holds the position of Chairman at each of General Healthcare Group Ltd, Symbian Software Limited and Vertex Data Science Limited. He is a member of the Advisory Board of the UK Defence Academy and a member of the Council of Imperial College.

From 2000 until 2004, Sir Peter was chief executive officer of the Office of Government Commerce, where he led a major overhaul of government procurement practice and an efficiency review of the UK public sector.

From 1999 to 2000, Sir Peter was chief operating officer and a member of the Board of BAe Systems. From 1994 to 1999, he was managing director of GEC Marconi where he was responsible for GEC's interests in defence, aerospace electronics and naval shipbuilding.

From 1990 to 1994, Sir Peter was managing director of GPT, the telecommunications joint venture between GEC and Siemens. From 1987 to 1990, Sir Peter was managing director of STC Telecommunications.

Sir Peter is a chartered engineer and holds a first class degree in mathematics from Cambridge University.

About Tate & Lyle:

Tate & Lyle is a world leading manufacturer of renewable food and industrial ingredients. It uses innovative technology to transform corn and sugar into value-added ingredients for customers in the food, beverage, pharmaceutical, cosmetic, paper, packaging and building industries. The Company is a leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients, and citric acid. Tate & Lyle is the world number-one in industrial starches and is the sole manufacturer of SPLENDA® Sucralose.

Headquartered in London, Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company operates more than 50 production facilities throughout Europe, the Americas and South East Asia. In the year to 31 March 2007, it employed 6,488 people in its subsidiaries and joint ventures, and sales totalled £3.4 billion. Additional information can be found on http://www.tateandlyle.com.

SPLENDA® is a trademark of McNeil Nutritionals, LLC

Copyright Business Wire 2008

Date   Source Headline
26th Jun 20245:38 pmRNSTransaction in Own Shares
25th Jun 20245:50 pmRNSTransaction in Own Shares
24th Jun 20245:35 pmRNSTransaction in Own Shares
24th Jun 20243:30 pmRNSHolding(s) in Company
21st Jun 20245:45 pmRNSTransaction in Own Shares
21st Jun 20242:45 pmRNSUpdate to the Notice of AGM 2024
20th Jun 20246:03 pmRNSTransaction in Own Shares
20th Jun 20247:05 amRNSLaunch of Share Buyback
20th Jun 20247:00 amRNSCombination of Tate & Lyle and CP Kelco
4th Jun 20245:22 pmRNSAnnual Financial Report and Notice of AGM
4th Jun 202411:00 amRNSDirector/PDMR Shareholding
3rd Jun 202412:00 pmRNSTotal Voting Rights
30th May 202412:15 pmRNSHolding(s) in Company
23rd May 20247:00 amRNSFinal Results
23rd May 20247:00 amRNSSale of remaining interest in Primient JV to KPS
20th May 20241:00 pmRNSDirectorate Change
17th May 20243:30 pmRNSHolding(s) in Company
14th May 20243:30 pmRNSHolding(s) in Company
13th May 202410:00 amRNSHolding(s) in Company
8th May 20243:15 pmRNSHolding(s) in Company
1st May 20242:30 pmRNSTotal Voting Rights
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.